# CORRESP — Moleculin Biotech, Inc.  (MBRX)  (CIK 0001659617)

> <strong>Moleculin Biotech, Inc.  (MBRX)  (CIK 0001659617) → SEC staff</strong> · filed 2026-04-10 · ticker MBRX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001437749-26-012014
- **Form:** CORRESP
- **Filer:** Moleculin Biotech, Inc.  (MBRX)  (CIK 0001659617)
- **CIK:** 0001659617
- **Ticker:** MBRX
- **Filed:** 2026-04-10
- **SIC industry:** 2834
- **HQ:** Houston, TX

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1659617/000143774926012014/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1659617&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Moleculin Biotech, Inc.  (MBRX)  (CIK 0001659617)

- UPLOAD — 2026-04-02 — /comment-letter/0000000000-26-003361
- UPLOAD — 2026-01-02 — /comment-letter/0000000000-26-000020
- CORRESP — 2026-01-02 — /comment-letter/0001437749-26-000028
- CORRESP — 2025-09-29 — /comment-letter/0001437749-25-029979
- UPLOAD — 2025-09-24 — /comment-letter/0000000000-25-010407

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Moleculin Biotech, Inc.  (MBRX)  (CIK 0001659617) (CIK 0001659617), filed 2026-04-10, accession 0001437749-26-012014. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001437749-26-012014.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*